FR2744725B1 - SPECIFIC ANTIBODIES OF COMPLEXES FORMED BY GLYCOPROTEINS E1 AND E2 OF THE HEPATITIS C VIRUS, METHODS FOR DETERMINING THE PRESENCE, AND ISOLATION OF THESE COMPLEXES - Google Patents

SPECIFIC ANTIBODIES OF COMPLEXES FORMED BY GLYCOPROTEINS E1 AND E2 OF THE HEPATITIS C VIRUS, METHODS FOR DETERMINING THE PRESENCE, AND ISOLATION OF THESE COMPLEXES

Info

Publication number
FR2744725B1
FR2744725B1 FR9601651A FR9601651A FR2744725B1 FR 2744725 B1 FR2744725 B1 FR 2744725B1 FR 9601651 A FR9601651 A FR 9601651A FR 9601651 A FR9601651 A FR 9601651A FR 2744725 B1 FR2744725 B1 FR 2744725B1
Authority
FR
France
Prior art keywords
complexes
glycoproteins
hepatitis
virus
isolation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9601651A
Other languages
French (fr)
Other versions
FR2744725A1 (en
Inventor
Jean Dubuisson
Andre Pillez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR9601651A priority Critical patent/FR2744725B1/en
Priority to PCT/FR1997/000232 priority patent/WO1997029129A1/en
Priority to AU17283/97A priority patent/AU1728397A/en
Publication of FR2744725A1 publication Critical patent/FR2744725A1/en
Application granted granted Critical
Publication of FR2744725B1 publication Critical patent/FR2744725B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
FR9601651A 1996-02-09 1996-02-09 SPECIFIC ANTIBODIES OF COMPLEXES FORMED BY GLYCOPROTEINS E1 AND E2 OF THE HEPATITIS C VIRUS, METHODS FOR DETERMINING THE PRESENCE, AND ISOLATION OF THESE COMPLEXES Expired - Fee Related FR2744725B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9601651A FR2744725B1 (en) 1996-02-09 1996-02-09 SPECIFIC ANTIBODIES OF COMPLEXES FORMED BY GLYCOPROTEINS E1 AND E2 OF THE HEPATITIS C VIRUS, METHODS FOR DETERMINING THE PRESENCE, AND ISOLATION OF THESE COMPLEXES
PCT/FR1997/000232 WO1997029129A1 (en) 1996-02-09 1997-02-05 Antibodies specific for mature complexes formed by hepatitis c virus glycoproteins e1 and e2
AU17283/97A AU1728397A (en) 1996-02-09 1997-02-05 Antibodies specific for mature complexes formed by hepatitis c virus glycoproteins e1 and e2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9601651A FR2744725B1 (en) 1996-02-09 1996-02-09 SPECIFIC ANTIBODIES OF COMPLEXES FORMED BY GLYCOPROTEINS E1 AND E2 OF THE HEPATITIS C VIRUS, METHODS FOR DETERMINING THE PRESENCE, AND ISOLATION OF THESE COMPLEXES

Publications (2)

Publication Number Publication Date
FR2744725A1 FR2744725A1 (en) 1997-08-14
FR2744725B1 true FR2744725B1 (en) 1998-04-30

Family

ID=9489057

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9601651A Expired - Fee Related FR2744725B1 (en) 1996-02-09 1996-02-09 SPECIFIC ANTIBODIES OF COMPLEXES FORMED BY GLYCOPROTEINS E1 AND E2 OF THE HEPATITIS C VIRUS, METHODS FOR DETERMINING THE PRESENCE, AND ISOLATION OF THESE COMPLEXES

Country Status (3)

Country Link
AU (1) AU1728397A (en)
FR (1) FR2744725B1 (en)
WO (1) WO1997029129A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3714499A (en) * 1998-05-14 1999-11-29 Pasteur Merieux Serums Et Vaccins Hepatitis c virus mimotopes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO115446B1 (en) * 1990-11-08 2000-02-28 Chiron Corp Process for producing purified asialoglycoproteins from hepatitis c virus

Also Published As

Publication number Publication date
AU1728397A (en) 1997-08-28
WO1997029129A1 (en) 1997-08-14
FR2744725A1 (en) 1997-08-14

Similar Documents

Publication Publication Date Title
PT773957E (en) HEPATITIS C INNOVATIVE HEPATITIS E1 AND E2 POLYPEPTIDES, AND METHODS OF OBTAINING THEMSELVES
FR07C0046I2 (en) BETA-L-2'-DESOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B
HUP0001395A1 (en) Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication
FI964032A (en) Trusted agents for open e-commerce
IL118471A0 (en) A positive-stranded RNA virus-derived composition methods for making compositions utilizing the same assays for the detection of and vaccines against said viruses
FR2745492B1 (en) PACKAGING ASSEMBLY FOR LYOPHILIZED PREPARATIONS
DE69738312D1 (en) HEPATITIS B MONOCLONAL ANTIBODIES
FR2722681B1 (en) MEN'S BABY
FI951198A0 (en) New branched hybrid and group peptides effective in the diagnosis and detection of non-A, non-B hepatitis
FR2744725B1 (en) SPECIFIC ANTIBODIES OF COMPLEXES FORMED BY GLYCOPROTEINS E1 AND E2 OF THE HEPATITIS C VIRUS, METHODS FOR DETERMINING THE PRESENCE, AND ISOLATION OF THESE COMPLEXES
DE69621837D1 (en) METHODS FOR DETECTING ALZHEIMERSCH DISEASE
FR2737209B1 (en) PEPTIDE CAPABLE OF BEING RECOGNIZED BY ANTIBODIES RECOGNIZING THE C33 ANTIGEN OF HEPATITIS C VIRUS
IL118364A0 (en) A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus
DE69929468D1 (en) IMPROVED SPECIFICITY IN THE DETECTION OF ANTI-RUBELLA IgM ANTIBODIES
NO994749D0 (en) Process for the preparation of tetraazamacrocycles
KR970053199U (en) Men's shorts
KR960003693U (en) Men's panties
KR970015890U (en) Men's shorts
FI952778A0 (en) Hepatitis C virus (HCV) 3-non-structural peptides, antibodies against them and methods for detecting HCV
DE29619826U1 (en) Men's underpants
AU2370692A (en) Method to detect antibodies against hepatitis c virus and kits for the use thereof
NO176664C (en) Process for the preparation of tripeptide aldehydes
DE29806193U1 (en) Men's underpants
KR950026320U (en) Men's briefs
KR960006815U (en) Men's briefs

Legal Events

Date Code Title Description
ST Notification of lapse